A, G., O, S., & E, M. (2022). Co-prescription of metoprolol and CYP2D6-inhibiting antidepressants before and after implementation of an optimized drug interaction database in Norway. European journal of clinical pharmacology, 78(10), 1623. https://doi.org/10.1007/s00228-022-03364-5
Chicago Style (17th ed.) CitationA, Gedde-Dahl, Spigset O, and Molden E. "Co-prescription of Metoprolol and CYP2D6-inhibiting Antidepressants Before and After Implementation of an Optimized Drug Interaction Database in Norway." European Journal of Clinical Pharmacology 78, no. 10 (2022): 1623. https://doi.org/10.1007/s00228-022-03364-5.
MLA (9th ed.) CitationA, Gedde-Dahl, et al. "Co-prescription of Metoprolol and CYP2D6-inhibiting Antidepressants Before and After Implementation of an Optimized Drug Interaction Database in Norway." European Journal of Clinical Pharmacology, vol. 78, no. 10, 2022, p. 1623, https://doi.org/10.1007/s00228-022-03364-5.